148 related articles for article (PubMed ID: 22563780)
1. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II.
Czaja AJ
Inflamm Allergy Drug Targets; 2012 Oct; 11(5):351-63. PubMed ID: 22563780
[TBL] [Abstract][Full Text] [Related]
2. Cell mediators of autoimmune hepatitis and their therapeutic implications.
Montano-Loza AJ; Czaja AJ
Dig Dis Sci; 2015 Jun; 60(6):1528-42. PubMed ID: 25487192
[TBL] [Abstract][Full Text] [Related]
3. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.
Czaja AJ
Curr Pharm Des; 2011; 17(29):3120-40. PubMed ID: 21902661
[TBL] [Abstract][Full Text] [Related]
4. Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.
Czaja AJ
Dig Dis Sci; 2010 Oct; 55(10):2712-26. PubMed ID: 20108036
[TBL] [Abstract][Full Text] [Related]
5. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
Czaja AJ
Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041
[TBL] [Abstract][Full Text] [Related]
6. Emerging treatments for autoimmune hepatitis.
Czaja AJ
Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):317-26. PubMed ID: 14561179
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis.
Lapierre P; Lamarre A
J Immunol Res; 2015; 2015():479703. PubMed ID: 26106627
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Kuhn C; Weiner HL
Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
[TBL] [Abstract][Full Text] [Related]
9. Achieving antigen-specific tolerance in diabetes: regulating specifically.
Chen W; Bluestone JA; Herold KC
Int Rev Immunol; 2005; 24(5-6):287-305. PubMed ID: 16318983
[TBL] [Abstract][Full Text] [Related]
10. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.
Czaja AJ
Dig Dis Sci; 2018 Jul; 63(7):1706-1725. PubMed ID: 29671161
[TBL] [Abstract][Full Text] [Related]
11. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
12. Low-dose anti-CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized mice.
Marceau G; Yang R; Lapierre P; Béland K; Alvarez F
Liver Int; 2015 Jan; 35(1):275-84. PubMed ID: 24517723
[TBL] [Abstract][Full Text] [Related]
13. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets.
Czaja AJ
Aliment Pharmacol Ther; 2014 Aug; 40(3):261-79. PubMed ID: 24890045
[TBL] [Abstract][Full Text] [Related]
14. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
Sun R; Tian Z; Kulkarni S; Gao B
J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
[TBL] [Abstract][Full Text] [Related]
16. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
17. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
[TBL] [Abstract][Full Text] [Related]
19. Adoptive cell transfer in autoimmune hepatitis.
Czaja AJ
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):821-36. PubMed ID: 25719553
[TBL] [Abstract][Full Text] [Related]
20. Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.
Mele D; Bossi G; Maggiore G; Oliviero B; Mantovani S; Bonelli B; Mondelli MU; Varchetta S
Clin Immunol; 2018 Mar; 188():31-37. PubMed ID: 29233784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
